NCT06200961View on ClinicalTrials.gov

Trans-nasal Endoscopy for Bariatric Patients

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

December 31, 2026

Conditions
ObesityObesity, MorbidObeseGI DisordersGastrointestinal Diseases
Interventions
DEVICE

Transnasal Endoscopy

Unsedated endoscopic evaluation through the nose.

PROCEDURE

Esophagogastroduodenoscopy

Sedated endoscopic evaluation through the mouth.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

Sponsors

Collaborators (1)

EvoEndo, Inc.
All Listed Sponsors
collaborator

EvoEndo, Inc.

UNKNOWN

lead

Christopher C. Thompson, MD, MSc

OTHER

NCT06200961 - Trans-nasal Endoscopy for Bariatric Patients | Biotech Hunter | Biotech Hunter